Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
25,726,377
-
Total 13F shares
-
15,918,361
-
Share change
-
+8,356,231
-
Total reported value
-
$971,295,549
-
Put/Call ratio
-
50%
-
Price per share
-
$61.02
-
Number of holders
-
110
-
Value change
-
+$514,747,070
-
Number of buys
-
89
-
Number of sells
-
23
Institutional Holders of Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) as of Q1 2024
As of 31 Mar 2024,
Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,918,361 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Cormorant Asset Management, LP, Point72 Asset Management, L.P., RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, VR Adviser, LLC, Verition Fund Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, and PFM Health Sciences, LP.
This page lists
110
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.